S-3-hydroxyphenyl (N-hydroxycarbamamido) (diphenyl) ethanethioate derivatives as potential inhibitors of 5 -Lipoxygenase (5-LOX)
DOI:
https://doi.org/10.18687/LACCEI2023.1.1.1222Palabras clave:
5-Lipoxygenase, molecular docking, anti-inflammatory drugsResumen
We have designed and docked derivatives of a new anti-inflammatory compound into the crystal structure of the Lipoxygenase-5 (LOX-5) enzyme. We found that four derivatives have the same ability to inhibit the activity of the enzyme as the anti-inflammatory drug Zileuton. This information may help us develop new compounds to treat inflammation.Descargas
Publicado
2023-07-27
Número
Sección
Articles
Derechos de autor
Derechos de autor 2023 LACCEI
Licencia
Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional.
Cómo citar
Ariza-Rua, Danilo, Rebollo, Juan Alberto, Chavarro-Mesa, Edisson, & Ballestas-Casallas, Yamil. (2023). S-3-hydroxyphenyl (N-hydroxycarbamamido) (diphenyl) ethanethioate derivatives as potential inhibitors of 5 -Lipoxygenase (5-LOX). LACCEI, 1(8). https://doi.org/10.18687/LACCEI2023.1.1.1222